Cannabis Law Report

JANUARY 24, 2022

Moreover, an increase in the preference for Cannabidiol (CBD)-based products, such as food & beverages, cosmetics, and wellness products in the country supports market growth. Key Topics Covered: Chapter 1 Methodology and Scope. North America Legal Cannabis Number of clinical trials. Chapter 2 Executive Summary.

Legalization 52

Legalization Supply Chain Chronic Pain Recreational 52

Project CBD

FEBRUARY 28, 2023

Under section 201(ff)(3)(B) of the Federal Food, Drug, and Cosmetic Act — in what some refer to as the “drug preclusion clause” 4 — any substance that is an active ingredient in an approved drug product, or that is being publicly investigated as such, is excluded from the definition of a legal dietary supplement ingredient. 2021;56:530-543.

CBD 144

CBD Seed-To-Sale Food Access 144

Cannabis Law Report

SEPTEMBER 20, 2021

Nanomerics”) to use Nanomeric’s molecular envelope platform technology (MET) for the nasal delivery of a cannabidiol (CBD) for the management of epilepsy in adults and children. Food and Drug Administration’s review. “We Nanomerics has initiated preclinical studies of VRP324.

Epilepsy 52

Epilepsy Research and Development Clinical Trials Chronic Pain 52

Cannabis Law Report

OCTOBER 6, 2021

Under the terms of this agreement, Sinclair Research will perform preclinical animal studies including method, dosage and toxicity as part of the enabling trials for an Investigational New Drug Application (“IND”) for AnQlar, as required by the U.S. Food and Drug Administration (“FDA”). Forward-Looking Statement.

Research and Development 52

Research and Development Clinical Trials Pharmaceutical Chronic Pain 52

Cannabis Law Report

DECEMBER 8, 2021

Charles River Laboratories, a renowned CRO engaged by Virpax to perform Food and Drug Administration (FDA) required pre-clinical studies, has completed a single dose pharmacokinetic study of dermal administration of Epoladerm in minipigs as part of the required Investigational New Drug Application (“IND”) enabling trials.

Clinical Trials 52

Clinical Trials Chronic Pain Pharmaceutical Topical 52

Cannabis Law Report

NOVEMBER 24, 2021

Chronic pain or pain were the conditions most frequently mentioned in articles about cannabis, followed by epilepsy, cancer or cancer pain, and nausea and chemotherapy. It was also used as a topical treatment for haemorrhoids, ear infection, and wounds (Aldrich 1997 ; Touw 1981 ). Refractory paediatric epilepsy. Conclusions.

Research and Development 52

Research and Development Medicine Access Media 52

The Cannigma

DECEMBER 22, 2021

Before the interview, we did a lot of complaining about Las Vegas and how we want to be back to Israeli food. We have autism and epilepsy. Then you will have CBD products initially, we think, only through on the food side of things, in the food supplement category. IR: Exactly. We’re 30 minutes apart.

Research and Development 79

Research and Development Oil Cannabis Clinical Trials 79

Cannabis Law Report

AUGUST 12, 2019

Indica plants are shorter and bushier and less suitable for farming for either industrial purposes or for production of food, but well-suited for producing medical marijuana. Terpenes are recognized as safe for human consumption by the Food and Drug Association and are used in a wide variety of food and cosmetic products.

CBD 40

CBD Terpenes Oil Tincture 40

Cannabis Law Report

JULY 12, 2019

Recent studies on the effectiveness of cannabidiol in the rare seizure disorders Dravet Syndrome and Lennox-Gastaut syndrome have prompted a biopharmaceutical company to perform clinical trials of its own to bring a cannabidiol based drug to the American market through the process of FDA approval. Lancet Neurol Dec 23 2015. Fabricio A.

Extraction 73

Extraction Pharmaceutical CBD Epilepsy 73

Cannabis Law Report

OCTOBER 17, 2019

Retailers such as Walgreens, CVS, Rite Aid, Kroger, Safeway, Nordstrom, and DSW are selling or plan to sell CBD-infused topical lotions, cosmetics, and even edibles where they are legally able to do so. Not only are makers of foods, health and beauty products, and supplements interested in CBD and THC.

Law 40

Law Seed-To-Sale Hemp Recreational 40